1997
Successful Treatment of Esthesioneuroblastoma and Neuroendocrine Carcinoma With Combined Chemotherapy and Proton Radiation: Results in 9 Cases
Search citation statements
Paper Sections
Select...
79
34
10
3
Citation Types
0
94
1
7
Year Published
1998
2025
Publication Types
Select...
101
12
2
Relationship
0
115
Authors
Journals
Cited by 115 publications
(102 citation statements)
References 19 publications
0
94
1
7
“…At least a partial response is reported in 60%–80% of patients with advanced SCC 11,13,14 . While results are less frequently reported for other pathologies, response rates seem to fall in a similar range 15–18 . In our cohort of all sinonasal malignancy that underwent IC, there was no significant difference in IC response based on tumor histology, although this analysis is limited by very small sample sizes in rarer histologies.…”
Section: Discussioncontrasting
confidence: 50%
“…At least a partial response is reported in 60%–80% of patients with advanced SCC 11,13,14 . While results are less frequently reported for other pathologies, response rates seem to fall in a similar range 15–18 . In our cohort of all sinonasal malignancy that underwent IC, there was no significant difference in IC response based on tumor histology, although this analysis is limited by very small sample sizes in rarer histologies.…”
Section: Discussioncontrasting
confidence: 50%
“…11,13,14 While results are less frequently reported for other pathologies, response rates seem to fall in a similar range. [15][16][17][18] In our cohort of all sinonasal malignancy that underwent IC, there was no significant difference in IC response based on tumor histology, although this analysis is limited by very small sample sizes in rarer histologies. The benefits of IC may include decreased morbidity/toxicity of definitive treatment due to tumor response, including possible orbital preservation.…”
Section: Discussionmentioning
confidence: 72%
“…A combination of cyclophosphamide, vincristine, and doxorubicin was used by some institutions 42 while others considered the use of cisplatin based regimens. Cisplatin combined with etoposide seems to be the most popular regimen used for ONB 46,47 . In our study 43 patients received chemotherapy.…”
Section: Discussionmentioning
confidence: 86%
“…Although early reports on chemotherapy in ENB focused on patients with recurrent or metastatic disease, adjuvant chemotherapy is now commonly used for patients with advanced locoregional disease. Numerous protocols have been published in literature presenting favourable results with cisplatin based chemotherapy [12,[19][20][21]. Two of our patients received post operative chemotherapy after RT, one having systemic metastasis and the other with regional recurrence.…”
Section: Discussionmentioning
confidence: 91%
